Search
Amber
go.drugbank.com/drugs/DB14326InvestigationalAmber is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Categories: Compounds used in a research, industrial, or household settingTabelecleucel
go.drugbank.com/drugs/DB17072ApprovedInvestigationalTabelecleucel is an innovative therapy that uses Epstein-Barr virus (EBV)-specific allogeneic cytotoxic T cells (CTLs). … [A253292,A253297,L43557] In October 2022, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended tabelecleucel be granted marketing authorization for the treatment of adult and
Unexpanded umbilical cord-derived allogeneic CD34- hematopoietic stem cells
go.drugbank.com/drugs/DB28348Approved[L54146] Zemcelpro was granted conditional marketing authorization in the European Union in August 2025 for use in allogeneic hematopoietic stem cell transplantation following myeloablative conditioning … in adult patients for whom a suitable donor is not available.
1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
go.drugbank.com/drugs/DB11331ApprovedWithdrawnPalmitoyloleoyl-phosphatidylglycerol was a component of Surfaxin, discontinued in 2017, which acted as a surfactant [FDA Label].
Salts: 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium saltSynonyms: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerolAclidinium
go.drugbank.com/drugs/DB08897ApprovedFDA approved on July 24, 2012. … Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD).
Mecasermin
go.drugbank.com/drugs/DB01277ApprovedInvestigationalThe rhIGF-1 protein is synthesized in bacteria (E. coli) that have been modified by the addition of the gene for human IGF-1. … IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges and a molecular weight of 7649 daltons.
Timtraxanib
go.drugbank.com/drugs/DB21515ExperimentalThe usage of the INN stem '-anib' in the name indicates that Timtraxanib is a angiogenesis inhibitor. Timtraxanib has a monoisotopic molecular weight of 621.31 Da.
Synonyms: N-ac-arg-leu-tyr-gluBarzuxetan
go.drugbank.com/drugs/DB21132ExperimentalThe usage of the INN stem '-xetan' in the name indicates that Barzuxetan is a chelating agent. Barzuxetan has a monoisotopic molecular weight of 594.2 Da.
Imarikiren
go.drugbank.com/drugs/DB19464InvestigationalThe usage of the INN stem '-kiren' in the name indicates that Imarikiren is a renin inhibitor. Imarikiren has a monoisotopic molecular weight of 499.32 Da.
Levonantradol
go.drugbank.com/drugs/DB19477ExperimentalThe usage of the INN stem '-adol/-adol-' in the name indicates that Levonantradol is a analgesic. Levonantradol has a monoisotopic molecular weight of 437.26 Da.